The reverse LICAP flap: A laterally based submammary perforator flap for breast reconstruction.


Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
09 2023
Historique:
received: 04 01 2023
accepted: 02 05 2023
medline: 29 8 2023
pubmed: 18 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

The traditional donor sites for autologous breast reconstruction include the abdomen, thigh, buttock, and posterior thorax. Herein, we describe the use of the reverse lateral intercostal perforator (LICAP) flap originating from the submammary region as an option for breast reconstruction. Fifteen patients (30 breasts) were included in this retrospective review. The procedure was performed for immediate reconstruction following a nipple sparing mastectomy utilizing an inframammary incision or an inverted T pattern with preservation of the fifth anterior intercostal perforator (n = 8), volume replacement after implant explantation (n = 5), and partial lower pole resurfacing with exteriorization of a portion of the LICAP skin paddle (n = 2). Flap survival was achieved in all patients. Three flaps (10%) had 1-2 cm of intraoperative distal tip ischemia, which was managed by excision prior to inset and closure. At the 12-month postoperative follow-up, stable results with good nipple position, breast shape, and projection were achieved in all patients. The reverse LICAP flap is a safe, effective, and reliable option for breast reconstruction following mastectomy.

Identifiants

pubmed: 37331037
pii: S1748-6815(23)00296-6
doi: 10.1016/j.bjps.2023.05.042
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

157-164

Informations de copyright

Copyright © 2023 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest Dr. Nahabedian is a consultant for Allergan/Abbvie and Stryker. The remaining authors have no potential conflicts of interest to disclose.

Auteurs

Esteban Spinelli (E)

Hospital San Martin La Plata University, Argentina.

Claudio Angrigiani (C)

Hospital San Martín University of Buenos Aires School of Medicine, Argentina. Electronic address: claudioangrigiani@icloud.com.

Alberto Rancati (A)

Hospital San Martín University of Buenos Aires School of Medicine, Argentina.

Julio Dorr (J)

Hospital San Martín University of Buenos Aires School of Medicine, Argentina.

Agustin Rancati (A)

Hospital San Martín University of Buenos Aires School of Medicine, Argentina.

Maurice Y Nahabedian (MY)

National Center for Plastic Surgery, McLean, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH